| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027405 |
| Receipt No. | R000031404 |
| Official scientific title of the study | Effect of ingestion of test food on immune parameters and state of health of healthy adults in summer: a randomized, double-blinded, placebo-controlled trial. |
| Date of disclosure of the study information | 2017/05/19 |
| Last modified on | 2017/11/20 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effect of ingestion of test food on immune parameters and state of health of healthy adults in summer: a randomized, double-blinded, placebo-controlled trial. | |
| Title of the study (Brief title) | Effect of ingestion of test food on immune parameters and state of health of healthy adults in summer: a randomized, double-blinded, placebo-controlled trial. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate effects of ingestion of test food on immune parameters and state of health of healthy adults in summer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Immune parameters (natural killer cell cytotoxicity, Neutrophil phagocytic capacity, sIgA)
State of health in summer (infectious diseases etc) |
| Key secondary outcomes | Balance of the autonomic nervous system
Cortisol |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of test food (high dose) for 12 weeks | |
| Interventions/Control_2 | Ingestion of test food (low dose) for 12 weeks | |
| Interventions/Control_3 | Ingestion of placebo for 12 weeks | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Aged from 20 to 64 years old | |||
| Key exclusion criteria | 1) Subjects with chronic diseases
2) Subjects in pregnancy or breast-feeding 3) Subjects with milk allergy 4) Subjects who consume test food habitually 5) Subjects who have a history of serious disorders in liver, kidney, heart, lung, gastro-intestine, blood, endocrine system, or metabolic system etc. 6) Subjects who are judged inappropriate to this trial by the investigator |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Masahiko Kurokawa |
| Organization | Kyushu University of Health and Welfare |
| Division name | Department of Biochemistry, Graduate School of Clinical Pharmacy |
| Address | 1714-1 Yoshino, Nobeoka, Miyazaki, 882-8508 JAPAN |
| TEL | 0982-23-5574 |
| b2mk@phoenix.ac.jp | |
| Public contact | |
| Name of contact person | Masahiko Kurokawa |
| Organization | Kyushu University of Health and Welfare |
| Division name | Department of Biochemistry, Graduate School of Clinical Pharmacy |
| Address | 1714-1 Yoshino, Nobeoka, Miyazaki, 882-8508 JAPAN |
| TEL | 0982-23-5574 |
| Homepage URL | |
| b2mk@phoenix.ac.jp | |
| Sponsor | |
| Institute | Department of Biochemistry, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Morinaga Milk Industry Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031404 |